SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Sales for the quarter ended June 2024 of Rs. 693.72 million declined by -51.44% from Rs. 1428.49 millions.The Net Loss for the quarter ended June 2024 is Rs. -397.37 millions as compared to Net Loss of Rs. -82.06 millions of corresponding quarter ended June 2023Operating profit Margin for the quarter ended June 2024 slipped to -453.42% as compared to 48.33% of corresponding quarter ended June 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 693.72 1428.49 -51.44 693.72 1428.49 -51.44 4581.81 6281.66 -27.06
Other Income 9.07 16.97 -46.55 9.07 16.97 -46.55 55.84 130.36 -57.16
PBIDT -453.42 48.33 -1038.18 -453.42 48.33 -1038.18 -3.19 893.00 -100.36
Interest 70.46 64.67 8.95 70.46 64.67 8.95 252.44 207.40 21.72
PBDT -523.88 -16.34 3106.12 -523.88 -16.34 3106.12 -255.63 685.60 -137.29
Depreciation 92.80 94.00 -1.28 92.80 94.00 -1.28 363.13 337.12 7.72
PBT -616.68 -110.34 458.89 -616.68 -110.34 458.89 -618.76 348.48 -277.56
TAX -219.31 -28.28 675.50 -219.31 -28.28 675.50 -148.89 93.29 -259.60
Deferred Tax -219.31 -28.28 675.50 -219.31 -28.28 675.50 -148.89 93.29 -259.60
PAT -397.37 -82.06 384.24 -397.37 -82.06 384.24 -469.87 255.19 -284.13
Equity 196.10 196.06 0.02 196.10 196.06 0.02 196.09 196.06 0.02
PBIDTM(%) -65.36 3.38 -2031.86 -65.36 3.38 -2031.86 -0.07 14.22 -100.49

Astec Lifesciences Share Price

726.50 -22.90 (-3.06%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 665.00
PI Industries 3144.45
Bayer CropScience 4900.45
Sharda Cropchem 1109.70
Sumitomo Chemical 441.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×